ScholarIQanswers from OpenAlex

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>

PaperCitations, authors & open-access status

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> have?

ScholarIQcitation count

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> has 144 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> published?

ScholarIQyear

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> has 2002 year in the ScholarIQ index.

What is the open-access status of Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

ScholarIQoa status

Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> has green oa status in the ScholarIQ index.

What is the DOI of Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

ScholarIQdoi

The DOI for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is on the source record.

What is the PMID of Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

ScholarIQpmid

The PMID for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is on the source record.

What is the OpenAlex record for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>?

ScholarIQopenalex

The OpenAlex for Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i> is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial